Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating TVB-009P for relief of postmenopausal osteoporosis has completed; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TVB-009P

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2024-04-18